Use of PSK9 Inhibitors

MEET-THE-EXPERTS SESSION I

Use of PSK9 Inhibitors

4/27/2019
2:15 PM - 3:15 PM
Location: Convention Center 502 A

Savitha Subramanian, MD

Associate Professor
University of Washington

Dr. Savitha Subramanian is an associate professor of medicine at the University of Washington. She completed an endocrinology fellowship at Washington University in St. Louis and subsequently did a research fellowship at the University of Washington in Seattle WA. She is board certified in Endocrinology and Metabolism.

Dr. Subramanian’s clinical interests lie in lipidology, management of complex diabetes and general endocrinology. She has special expertise in managing individuals with partial lipodystrophy and genetic lipid disorders. Her research has focused on studying the molecular mechanisms driving inflammation in obese adipose tissue, liver and atherosclerosis. She is currently spearheading diabetes population health for UW Medicine and involved in development of standardization pathways for outpatient diabetes management for primary care. She has done extensive work as part of a collaborative care model for diabetes working with primary care physicians in the greater Seattle area.

Locally, Dr. Subramanian is involved in many teaching activities for trainees and clinicians. She is the co-chair of the popular Diabetes Update for Primary Care CME and chair of the Endocrinology Update CME courses for the University of Washington. She is a member of the Endocrine Self Assessment Program workgroup as well as the Lipid Management Guideline task force of the Endocrine Society.

Presentation(s):

Send Email for Savitha Subramanian

Chris K. Guerin, MD

Chief of Endocrinology
Tri-City Medical Center

Chris K. Guerin, MD, FACE, is a practicing Endocrinologist in Oceanside, California, where he is Chief of Endocrinology. He received his medical degree from Loyola Medical School in Maywood, IL, and completed his internship and residency at the Mayo Clinic in Rochester, MN. Dr. Guerin’s clinical fellowship was at Mayo Clinic, and he was a Post-Doctoral Scholar through the NIH at University of California, San Diego. He is on the Board of Directors of the Pacific Lipid Association and is especially interested in prevention of cardiovascular disease in Diabetic patients. Dr. Guerin is an Assistant Clinical Professor of Medicine at University of California, San Diego, and is a Past-President of California AACE.

Presentation(s):

Send Email for Chris Guerin


Assets

Use of PCSK9 Inhibitors: a real world approach

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Use of PCSK9 Inhibitors: a real world approach